Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125300531 | 12530053 | 1 | I | 20150731 | 20160629 | 20160706 | 20160706 | EXP | US-AMGEN-USASP2016085319 | AMGEN | 77.00 | YR | E | F | Y | 0.00000 | 20160706 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125300531 | 12530053 | 1 | PS | PROLIA | DENOSUMAB | 1 | Unknown | UNK | U | 125320 | SOLUTION FOR INJECTION | ||||||||
| 125300531 | 12530053 | 2 | C | ATENOLOL. | ATENOLOL | 1 | 50 MG, QD | 0 | 50 | MG | QD | ||||||||
| 125300531 | 12530053 | 3 | C | ATORVASTATIN | ATORVASTATIN | 1 | 20 MG, UNK | 0 | 20 | MG | |||||||||
| 125300531 | 12530053 | 4 | C | ASA | ASPIRIN | 1 | 81 MG, UNK | 0 | 81 | MG | |||||||||
| 125300531 | 12530053 | 5 | C | LUMIGAN | BIMATOPROST | 1 | 1 DROP EACH EYE | 0 | |||||||||||
| 125300531 | 12530053 | 6 | C | VIACTIV /00751501/ | 2 | 500 MG, UNK | 0 | 500 | MG | ||||||||||
| 125300531 | 12530053 | 7 | C | VITAMIN D | CHOLECALCIFEROL | 1 | 500 IU, UNK | 0 | 500 | IU | |||||||||
| 125300531 | 12530053 | 8 | C | VITAMIN K | PHYTONADIONE | 1 | 40 MUG, BID | 0 | 40 | UG | BID | ||||||||
| 125300531 | 12530053 | 9 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 0.025 MG, UNK | 0 | .025 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125300531 | 12530053 | 1 | Osteoporosis postmenopausal |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125300531 | 12530053 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125300531 | 12530053 | Asthenia | |
| 125300531 | 12530053 | Cardiac disorder | |
| 125300531 | 12530053 | Discomfort | |
| 125300531 | 12530053 | Fatigue | |
| 125300531 | 12530053 | Hypertension | |
| 125300531 | 12530053 | Unevaluable event |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125300531 | 12530053 | 1 | 20150415 | 0 |